At the news
? NEUTRALIMPACT 5/10 CLUSTER filed Feb 26, 2026 at 19:00 ET
Krystal Biotech insiders executed a cluster of trades over the past week, including open-market sales totaling $4.4 million. CEO Krish S. Krishnan and President of R&D Suma Krishnan exercised stock options (non-cash), while Chief Accounting Officer Kathryn Romano sold $200,700 worth of shares and also exercised options. Director Daniel Janney sold over $4.4 million in three transactions, representing the bulk of the activity.
- Director Daniel Janney sold 15,233 shares in open-market transactions for $4.395 million over three days.
- CEO Krish S. Krishnan and President of R&D Suma Krishnan exercised options for 8,750 and 22,500 shares respectively (non-cash events).
- Chief Accounting Officer Kathryn Romano sold 750 shares for $200,700 and exercised 7,500 options (non-cash).
- Total open-market sales in the cluster: $4.4 million.
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access